RB1 and cancer: When cancer occurs, the control of checkpoints often becomes dysfunctional, including abnormal expression of the RB gene and mis-regulation of CDKs, resulting in dysregulated cell cycle activity, causing hyper-proliferation leading to cancer or enabling cell loss [16, 58].